2-(((3S,9R,10S,13R,14R,17R)-10,13-Dimethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran

Ref. TR-D723450

Informação sobre produto

• Nome: 2-(((3S,9R,10S,13R,14R,17R)-10,13-Dimethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran

Descrição

Applications 2-(((3S,9R,10S,13R,14R,17R)-10,13-Dimethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran is an intermediate in the synthesis of 5α-Cholesta-7,24-diene-3β-ol (C431505), which is the derivative of Zymosterol (Z701520). It can also be used for identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology.
References Sato, Y., et al.: J. Lipid Res., 53, 567 (2012); Schoenheimer, et al.: J. Biol. Chem., 105, 355 (1934);

• Marca: TRC

Propriedades químicas

• Peso molecular: 468.754
• Fórmula: C₃₂H₅₂O₂
• Cor/forma: White Solid
• InChI: InChI=1S/C32H52O2/c1-22(2)9-8-10-23(3)27-14-15-28-26-13-12-24-21-25(34-30-11-6-7-20-33-30)16-18-31(24,4)29(26)17-19-32(27,28)5/h9,13,23-25,27-30H,6-8,10-12,14-21H2,1-5H3/t23-,24?,25+,27-,28+,29+,30?,31+,32-/m1/s1
• Chave InChI: InChIKey=JRMMSXUCDNGNAC-GAKMPBCGSA-N
• SMILES: CC(C)=CCC[C@@H](C)[C@H]1CC[C@H]2C3=CCC4C[C@@H](OC5CCCCO5)CC[C@]4(C)[C@H]3CC[C@@]21C